drugset / Trial / NCT03120533

Treprostinil Iontophoresis in Systemic Sclerosis Digital UlcErations. A Proof of Concept Study

NCT03120533

RandomizedCrossoverQuadruple-blindTreatment

Summary

The study is conducted to confirm the good tolerance of a continuous cathodal iontophoresis of the treprostinil hydrogel administered during 10 days on the pulp of the finger of healthy volunteer and on the ischemic digital ulcerations of Systemic Sclerosis patients, particularly to estimate the cutaneous tolerance of the procedure and the effect on the blood pressure.

Timeline

Start
2017-06-20
Primary completion
2019-06-03
Completion
2019-06-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Treprostinil Other / unclassified Other

Indications